Nutra Pharma is providing updates regarding the marketing and distribution of the Company’s Over-the-Counter products: Nyloxin, Pet Pain-Away and Equine Pain-Away. March 3, 2020 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HI